Singapore-based cell therapy biotech Tessa Therapeutics has shut down, according to two sources that worked with the biotech. The company formally shut its doors Friday, June 30, according to a ...

TESSA Therapeutics, one of the top-funded biotech startups in Singapore, will soon enter liquidation after failing to find investors to continue funding the development of its cancer treatment cell ...

The biotech's CAR-T therapies target cancer cells expressing the CD30 protein, such as the autologous CD30-CAR-T therapy called TT11 and the allogeneic CD30 CAR EBVST therapy named TT11X.